glp-1 podcast How GLP-1s are changing everyone's diets GLP-1 Hub: Support, Community, and

295: E350E355 [DOI] [PMC free article] [PubMed] [Google Scholar] 151.Yavropoulou MP, Kotsa K, Kesisoglou I, et al

Additionally, with equivocal findings in DR and NAION, discussing personalized ocular risk of starting GLP-1RA in patients is key, and considering increased follow-up frequency after medication initiation may be warranted

Yohimbine directly induces cardiotoxicity on human-induced pluripotent stem cell-derived cardiomyocytes

Research shows that semaglutide users often lose about 1520% of their body weight, while those taking tirzepatide may see even greater results, with weight loss reaching 2025%

Patients who do their homework before enrolling - who confirm current pricing, pharmacy licensing, dosing instructions, cancellation terms, and regulatory status directly with the platform and their clinician - are the ones who make fully informed decisions

using them is a sign of smart play, not weakness